PRR11 promotes ccRCC tumorigenesis by regulating E2F1 stability

Proline rich 11 (PRR11), a novel tumor-related gene, has been identified in different tumors. However, the relevant biological functions of PRR11 in human clear cell renal cell carcinoma (ccRCC) have not been studied. In this study, we first identified PRR11 as a biomarker of ccRCC and predictor of...

Full description

Bibliographic Details
Main Authors: Siming Chen, Zhiwen He, Tianchen Peng, Fenfang Zhou, Gang Wang, Kaiyu Qian, Lingao Ju, Yu Xiao, Xinghuan Wang
Format: Article
Language:English
Published: American Society for Clinical investigation 2021-10-01
Series:JCI Insight
Subjects:
Online Access:https://doi.org/10.1172/jci.insight.145172
_version_ 1818549300755431424
author Siming Chen
Zhiwen He
Tianchen Peng
Fenfang Zhou
Gang Wang
Kaiyu Qian
Lingao Ju
Yu Xiao
Xinghuan Wang
author_facet Siming Chen
Zhiwen He
Tianchen Peng
Fenfang Zhou
Gang Wang
Kaiyu Qian
Lingao Ju
Yu Xiao
Xinghuan Wang
author_sort Siming Chen
collection DOAJ
description Proline rich 11 (PRR11), a novel tumor-related gene, has been identified in different tumors. However, the relevant biological functions of PRR11 in human clear cell renal cell carcinoma (ccRCC) have not been studied. In this study, we first identified PRR11 as a biomarker of ccRCC and predictor of poor prognosis by bioinformatics. Then, we showed that PRR11 silencing substantially reduced ccRCC cell proliferation and migration in vitro and in vivo. Importantly, we found that PRR11 induced the degradation of the E2F1 protein through its interaction with E2F1, and PRR11 reduced the stability of the E2F1 protein in ccRCC cells, thereby affecting cell cycle progression. Further results indicated that the downregulation of E2F1 expression partially reversed the changes in ccRCC cell biology caused by PRR11 deletion. In addition, we showed that PRR11 was a target gene of c-Myc. The transcription factor c-Myc may have promoted the expression of PRR11 in ccRCC cells by binding to the PRR11 promoter region, thereby accelerating the progression of ccRCC. In summary, we found that PRR11 served as an oncogene in ccRCC, and PRR11 reduced the protein stability of E2F1 and could be activated by c-Myc.
first_indexed 2024-12-12T08:31:34Z
format Article
id doaj.art-6890ec4f4bd240a8a8727a98c3d6249b
institution Directory Open Access Journal
issn 2379-3708
language English
last_indexed 2024-12-12T08:31:34Z
publishDate 2021-10-01
publisher American Society for Clinical investigation
record_format Article
series JCI Insight
spelling doaj.art-6890ec4f4bd240a8a8727a98c3d6249b2022-12-22T00:31:05ZengAmerican Society for Clinical investigationJCI Insight2379-37082021-10-01619PRR11 promotes ccRCC tumorigenesis by regulating E2F1 stabilitySiming ChenZhiwen HeTianchen PengFenfang ZhouGang WangKaiyu QianLingao JuYu XiaoXinghuan WangProline rich 11 (PRR11), a novel tumor-related gene, has been identified in different tumors. However, the relevant biological functions of PRR11 in human clear cell renal cell carcinoma (ccRCC) have not been studied. In this study, we first identified PRR11 as a biomarker of ccRCC and predictor of poor prognosis by bioinformatics. Then, we showed that PRR11 silencing substantially reduced ccRCC cell proliferation and migration in vitro and in vivo. Importantly, we found that PRR11 induced the degradation of the E2F1 protein through its interaction with E2F1, and PRR11 reduced the stability of the E2F1 protein in ccRCC cells, thereby affecting cell cycle progression. Further results indicated that the downregulation of E2F1 expression partially reversed the changes in ccRCC cell biology caused by PRR11 deletion. In addition, we showed that PRR11 was a target gene of c-Myc. The transcription factor c-Myc may have promoted the expression of PRR11 in ccRCC cells by binding to the PRR11 promoter region, thereby accelerating the progression of ccRCC. In summary, we found that PRR11 served as an oncogene in ccRCC, and PRR11 reduced the protein stability of E2F1 and could be activated by c-Myc.https://doi.org/10.1172/jci.insight.145172Cell biologyNephrology
spellingShingle Siming Chen
Zhiwen He
Tianchen Peng
Fenfang Zhou
Gang Wang
Kaiyu Qian
Lingao Ju
Yu Xiao
Xinghuan Wang
PRR11 promotes ccRCC tumorigenesis by regulating E2F1 stability
JCI Insight
Cell biology
Nephrology
title PRR11 promotes ccRCC tumorigenesis by regulating E2F1 stability
title_full PRR11 promotes ccRCC tumorigenesis by regulating E2F1 stability
title_fullStr PRR11 promotes ccRCC tumorigenesis by regulating E2F1 stability
title_full_unstemmed PRR11 promotes ccRCC tumorigenesis by regulating E2F1 stability
title_short PRR11 promotes ccRCC tumorigenesis by regulating E2F1 stability
title_sort prr11 promotes ccrcc tumorigenesis by regulating e2f1 stability
topic Cell biology
Nephrology
url https://doi.org/10.1172/jci.insight.145172
work_keys_str_mv AT simingchen prr11promotesccrcctumorigenesisbyregulatinge2f1stability
AT zhiwenhe prr11promotesccrcctumorigenesisbyregulatinge2f1stability
AT tianchenpeng prr11promotesccrcctumorigenesisbyregulatinge2f1stability
AT fenfangzhou prr11promotesccrcctumorigenesisbyregulatinge2f1stability
AT gangwang prr11promotesccrcctumorigenesisbyregulatinge2f1stability
AT kaiyuqian prr11promotesccrcctumorigenesisbyregulatinge2f1stability
AT lingaoju prr11promotesccrcctumorigenesisbyregulatinge2f1stability
AT yuxiao prr11promotesccrcctumorigenesisbyregulatinge2f1stability
AT xinghuanwang prr11promotesccrcctumorigenesisbyregulatinge2f1stability